Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40013586
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
22/09/2022
Statut
Classification
1.5°C
Année cible
2030
Amgen commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2027 from a 2019 base year. Amgen also commits to increase annual sourcing of renewable electricity from 29% in 2019 to 100% by 2027, to continue annually sourcing of 100% renewable electricity through 2030. Amgen further commits that 73% of its suppliers by spend covering upstream purchased goods and services and capital goods will have science- based targets by 2027.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
LEI
62QBXGPJ34PQ72Z12S66
Source : Science Based Targets initiative | Données publiques